Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sascha Hoppe"'
Autor:
Patrick S. Plum, Timo Hess, Denis Bertrand, Isabelle Morgenstern, Oscar Velazquez Camacho, Christoph Jonas, Christina Alidousty, Britta Wagner, Stephanie Roessler, Thomas Albrecht, Jessica Becker, Vanessa Richartz, Barbara Holz, Sascha Hoppe, Huay Mei Poh, Burton Kuan Hui Chia, Cheryl Xueli Chan, Thushangi Pathiraja, Audrey SM Teo, Jens U. Marquardt, Alexis Khng, Michael Heise, Yao Fei, René Thieme, Sebastian Klein, Jing Han Hong, Simona O Dima, Irinel Popescu, Maria Hoppe‐Lotichius, Reinhard Buettner, Anja Lautem, Gerd Otto, Alexander Quaas, Niranjan Nagarajan, Steve Rozen, Bin Tean Teh, Benjamin Goeppert, Uta Drebber, Hauke Lang, Patrick Tan, Ines Gockel, Johannes Schumacher, Axel M. Hillmer
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 6, Pp n/a-n/a (2024)
Abstract Background Cholangiocarcinoma (CCA) is a fatal cancer of the bile duct with a poor prognosis owing to limited therapeutic options. The incidence of intrahepatic CCA (iCCA) is increasing worldwide, and its molecular basis is emerging. Environ
Externí odkaz:
https://doaj.org/article/26260a111e4f40929c73d9cf914a4148
Autor:
Christoph Jonas, Axel M. Hillmer, Reinhard Büttner, Alexander Quaas, Yue Zhao, Oscar Velazquez Camacho, Christoph Arolt, Patrick Sven Plum, Marten Christian Wenzel, Sascha Hoppe
Publikováno v:
Cancers, Vol 13, Iss 4300, p 4300 (2021)
Cancers
Cancers
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcinoma and squamous cell carcinoma, with adenocarcinoma of the esophagus (EAC) being more common in Western countries. Barrett’s esophagus (BE) describ
Autor:
Sascha Hoppe, Lydia Meder, Florian Gebauer, Roland T. Ullrich, Thomas Zander, Axel M. Hillmer, Reinhard Buettner, Patrick Plum, Julian Puppe, Wolfram Malter, Alexander Quaas
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4789
Introduction: The Trophoblast cell surface antigen 2 (TROP2) is expressed in many carcinomas and may represent a target for treatment. Sacituzumab govitecan (SG) is a TROP2–directed antibody-drug conjugate (ADC). Nearly nothing is known about the b
Autor:
Ningbo Fan, Chenghui Zhou, Christiane Bruns, Zhefang Wang, Axel M. Hillmer, Dai Li, Seung-Hun Chon, Florian Gebauer, Jiahui Li, Yue Zhao, Fanyu Liu, Alexandar Quaas, Sascha Hoppe, Patrick Sven Plum, Xiaolin Wu
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2403, p 2403 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2403, p 2403 (2021)
Simple Summary The multidrug resistance of EAC is one of the major obstacles to chemotherapeutic efficiency. Our study aims to explore the molecular mechanism of AKR1C3 as a novel therapeutic target to overcome chemotherapy resistance for EAC patient